BMS-639623 is a potent and orally active CCR3 antagonist with an IC 50 of 0.3 nM. BMS-639623 picomolar inhibition potency against eosinophil chemotaxis (IC 50 =38 pM). BMS-639623 can be used for the research of asthma.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > CCR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.